Johnson & Johnson (JNJ)

NYSE: JNJ · Real-Time Price · USD

154.13

-2.18 (-1.39%)

At close: May 01, 2025, 12:07 PM

Johnson & Johnson Income Statement

Financials in USD. Fiscal year is February - January.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 29, 2024	Dec 31, 2023	Jan 1, 2023	Jan 2, 2022	Jan 3, 2021	Dec 29, 2019	Dec 30, 2018	Dec 31, 2017	Jan 1, 2017
Revenue	88.82B	85.16B	79.99B	78.74B	82.58B	82.06B	81.58B	76.45B	71.89B
Cost of Revenue	27.47B	26.55B	24.6B	23.4B	28.43B	27.56B	27.09B	25.44B	21.79B
Gross Profit	61.35B	58.61B	55.39B	55.34B	54.16B	54.5B	54.49B	51.01B	50.1B
Operating Income	22.15B	23.41B	21.01B	20.94B	19.73B	20.97B	21.18B	18.9B	20.89B
Interest Income	1.33B	1.26B	490M	53M	111M	357M	611M	385M	368M
Pretax Income	16.69B	15.06B	19.36B	19.18B	16.5B	17.33B	18B	17.67B	19.8B
Net Income	14.07B	35.15B	17.94B	20.88B	14.71B	15.12B	15.3B	1.3B	16.54B
Selling & General & Admin	21.97B	20.11B	20.25B	20.12B	22.08B	22.18B	22.54B	21.52B	20.07B
Research & Development	17.23B	15.09B	14.13B	14.28B	12.34B	11.36B	10.78B	10.59B	9.14B
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	39.2B	35.2B	34.38B	34.4B	34.42B	33.53B	33.31B	32.11B	29.21B
Interest Expense	755M	772M	276M	183M	201M	318M	1B	934M	726M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	66.67B	61.75B	58.98B	57.8B	62.85B	61.09B	60.41B	57.55B	51B
Income Tax Expense	2.62B	1.74B	2.99B	1.38B	1.78B	2.21B	2.7B	16.37B	3.26B
Shares Outstanding (Basic)	2.41B	2.53B	2.61B	2.63B	2.63B	2.63B	2.66B	2.68B	2.71B
Shares Outstanding (Diluted)	2.43B	2.56B	2.66B	2.67B	2.67B	2.68B	2.73B	2.75B	2.79B
EPS (Basic)	5.84	13.88	6.83	7.93	5.59	5.74	5.75	0.48	6.08
EPS (Diluted)	5.79	13.72	6.73	7.81	5.51	5.63	5.61	0.47	5.93
EBITDA	24.78B	23.32B	26.61B	26.75B	23.93B	24.66B	25.93B	24.25B	24.28B
EBIT	17.44B	15.83B	19.64B	19.36B	16.7B	17.65B	19B	18.61B	20.53B
Depreciation & Amortization	7.34B	7.49B	6.97B	7.39B	7.23B	7.01B	6.93B	5.64B	3.75B